Dr Reddy's Laboratories Financial Overview
Dr Reddy's Laboratories's market cap is currently $11.73B. The company's EPS TTM is $0.196; its P/E ratio is 17.03; and it has a dividend yield of 0.65%. Dr Reddy's Laboratories is scheduled to report earnings on October 24, 2025, and the estimated EPS forecast is $0.17. See an overview of income statement, balance sheet, and cash flow financials.
